Chemopreventive potential of luteolin during colon carcinogenesis induced by 1,2-dimethylhydrazine

Ital J Biochem. Sep-Dec 2005;54(3-4):268-75.


We investigated the chemopreventive potential of luteolin on hepatic and circulatory lipid peroxidation and antioxidant status during 1,2-dimethylhydrazine induced colon carcinogenesis in rats. Rats were given a weekly subcutaneous injection of DMH at a dose of 20 mg/kg body weight for 15 weeks. Luteolin (0.2 mg/kg body weight/everyday p.o.) was given at the initiation and also at the postinitiation stages of carcinogenesis to DMH treated rats. The animals were sacrificed at the end of 30 weeks. Enhanced lipid peroxidation in the liver and circulation of tumor bearing rats was accompanied by a significant decrease in the levels of plasma and hepatic reduced glutathione (GSH), glutathione peroxidase (GPx), glutathione-S-transferase (GST), glutathione reductase (GR), superoxide dismutase (SOD), catalase (CAT), vitamin C, vitamin E and beta-carotene in DMH treated rats as compared to the control rats. Intragastric administration of luteolin (0.2mg/kg body weight) to DMH-treated rats significantly reduced the incidence and size of tumor in the colon, reduced lipid peroxidation levels and enhanced the plasma and hepatic activities of GSH, GPx, GST, GR, SOD, CAT, vitamin C, vitamin E and beta-carotene. Thus the chemopreventive efficacy of luteolin against colon carcinogenesis is evidenced by our preliminary studies which showed decreased incidence of tumors and the antiperoxidative and antioxidant effect of luteolin. Further study on the exact mechanism of action of luteolin in preventing colon carcinogenesis is yet to be elucidated.

MeSH terms

  • 1,2-Dimethylhydrazine
  • Animals
  • Anticarcinogenic Agents / administration & dosage
  • Anticarcinogenic Agents / therapeutic use*
  • Antioxidants / metabolism
  • Antioxidants / pharmacology
  • Biomarkers / metabolism
  • Colon / cytology
  • Colon / drug effects
  • Colon / metabolism
  • Colonic Neoplasms / chemically induced
  • Colonic Neoplasms / metabolism
  • Colonic Neoplasms / prevention & control*
  • Disease Models, Animal
  • Lipid Peroxidation / drug effects
  • Luteolin / administration & dosage
  • Luteolin / therapeutic use*
  • Male
  • Rats
  • Rats, Wistar


  • Anticarcinogenic Agents
  • Antioxidants
  • Biomarkers
  • 1,2-Dimethylhydrazine
  • Luteolin